Results 151 to 160 of about 1,828 (217)

Sugammadex for Reversal of Neuromuscular Blockade in Neonates and Infants Less than 2 Years Old: Results from a Phase IV Randomized Clinical Trial. [PDF]

open access: yesAnesthesiology
Mensah-Osman E   +10 more
europepmc   +1 more source

Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia

open access: closedSurvey of Anesthesiology, 2017
Abstract Background Residual postoperative paralysis from nondepolarizing neuromuscular blocking agents (NMBAs) is a known problem. This paralysis has been associated with impaired respiratory function, but the clinical significance remains unclear.
Catherine M. Bulka   +5 more
openalex   +3 more sources

Fumarates: Unique nondepolarizing neuromuscular blocking agents that are antagonized by cysteine

open access: closedJournal of Critical Care, 2009
It has been almost 20 years since the introduction of the last new nondepolarizing neuromuscular blocking agent into clinical practice, and research is ongoing to fill a clinical need for a nondepolarizing agent with a fast onset of effect and a short duration of action, as described by Savarese and Kitz [1] in 1975.
Cynthia A. Lien   +4 more
openalex   +3 more sources

Nondepolarizing Neuromuscular Blocking Agents

open access: closed, 2017
Neuromuscular blocking medications are an important part of the anesthetic management of many patients undergoing surgery. These drugs act at the neuromuscular junction on postsynaptic acetylcholine receptors. Muscle relaxants can be divided into depolarizing and nondepolarizing categories. Succinylcholine is the only depolarizing neuromuscular blocker
Erin Bettendorf, Zhiling Xiong
openalex   +2 more sources

Inhibition of human plasma cholinesterase and erythrocyte acetylcholinesterase by nondepolarizing neuromuscular blocking agents

open access: closedJournal of Anesthesia, 2000
The kinetics of the inhibition of human plasma cholinesterase (ChE) and erythrocyte acetylcholinesterase (AChE) by alcuronium, atracurium, d-tubocurarine, pancuronium, pipecuronium, and vecuronium were studied in blood drawn from 35 surgical patients.The activities of plasma ChE and erythrocyte AChE were determined by the calorimetric method of Ellman ...
Masato Kato   +5 more
openalex   +3 more sources

Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: Mechanisms at the cellular and molecular levels

open access: closedCritical Care Medicine, 2000
Long-term treatment with nondepolarizing neuromuscular blocking agents and corticosteroids in the intensive care unit is not benign, and an increasing number of patients with acute quadriplegic myopathy have been reported with increased use of these drugs.
Lars Larsson   +6 more
  +6 more sources

Interaction Between Nondepolarizing Neuromuscular Blocking Agents and Inhalational Anesthetics

open access: closedAnesthesia & Analgesia, 1989
Although many studies have presented data based on administration of nondepolarizing neuromuscular blocking agents to patients given inhalation anesthesia for 30-45 min, no data exist on the interaction in a clinical situation where the relaxant is administered immediately after the start of anesthesia.
J. Swen   +5 more
openalex   +4 more sources

Home - About - Disclaimer - Privacy